Dual time point imaging for F18-FDG-PET/CT does not improve the accuracy of nodal staging in non-small cell lung cancer patients
Authors:
- Julian M. M. RogaschJRJulian M. M. Rogasch
- Ingo G. SteffenISIngo G. Steffen
- Ivayla ApostolovaIAIvayla Apostolova
- H. Jost AchenbachHAH. Jost Achenbach
- Ferdinand L. G. A. SteinkrügerFSFerdinand L. G. A. Steinkrüger
- Jens SchreiberJSJens Schreiber
- Holger AmthauerHAHolger Amthauer
- Christian FurthChristian Furth
- 11 November 2015
- journal article
- Published by Springer Nature in European Radiology
- Vol. 26 (8) , 2808-2818
Abstract
To analyze the diagnostic performance of dual time point imaging (DTPI) for pre-therapeutic lymph node (LN) staging in non-small cell lung cancer (NSCLC). This was a retrospective analysis of 47 patients with NSCLC who had undergone DTPI by PET (early + delayed) using F18-fluorodeoxyglucose (FDG). PET raw data were reconstructed iteratively (point spread function + time-of-flight). LN uptake in PET was assessed visually (four-step score) and semi-quantitatively (SUVmax, SUVmean, ratios LN/primary, LN/liver, and LN/mediastinal blood pool). DTPI analyses included retention indices (RIs), Δ-ratios and changes in visual score. Histology or cytology served as standards of reference. Accuracy was determined based on ROC analyses. Thirty-six of 155 LNs were malignant. DTPI accuracy was low for all measures (visual assessment, 24.5%; RI SUVmax, 68.4%; RI SUVmean, 65.8%; Δ-ratios, 63.9-76.1%) and significantly inferior to early PET. Accuracies of early (range, 86.5–92.9%) and delayed PET (range, 85.2–92.9%) were comparable. At early PET, accuracy of the visual score (92.9%) was similar or superior to semi-quantitative analyses (range, 86.5–92.3%). Using a modern PET/CT device and novel image reconstruction, neither additional delayed PET nor DTPI analyses improved the accuracy of PET-based LN staging. Dedicated visual assessment criteria performed very well. • DTPI did not improve accuracy of PET-based LN staging in NSCLC. • Analyzed SUV ratios were not superior to LN SUVmax or SUVmean. • A four-step visual score may allow highly accurate, standardized LN assessment.Keywords
This publication has 24 references indexed in Scilit:
- Impact of Point Spread Function Reconstruction on Thoracic Lymph Node Staging With 18F-FDG PET/CT in Non–Small Cell Lung CancerClinical Nuclear Medicine, 2012
- Diagnostic value of fluorine 18 fluorodeoxyglucose positron emission tomography/computed tomography for the detection of metastases in non–small‐cell lung cancer patientsInternational Journal of Cancer, 2012
- Negative Predictive Value of Positron Emission Tomography and Computed Tomography for Stage T1-2N0 Non–Small-Cell Lung Cancer: A Meta-AnalysisClinical Lung Cancer, 2012
- The validity of preoperative lymph node staging guidelines of European Society of Thoracic Surgeons in non-small-cell lung cancer patients☆European Journal of Cardio-Thoracic Surgery, 2010
- FDG-PET/CT imaging in assessing mucin-producing non-small cell lung cancer with pathologic correlationAnnals of Nuclear Medicine, 2010
- FDG PET and PET/CT: EANM procedure guidelines for tumour PET imaging: version 1.0European Journal of Nuclear Medicine and Molecular Imaging, 2009
- Mediastinal Nodes in Patients with Non–Small Cell Lung Cancer: MRI Findings with PET/CT and Pathologic CorrelationAmerican Journal of Roentgenology, 2009
- Dual-Time-Point F-18 FDG PET/CT for Evaluation of Intrathoracic Lymph Nodes in Patients With Non-Small Cell Lung CancerClinical Nuclear Medicine, 2009
- Evaluation of Dual–Time-Point 18F-FDG PET for Staging in Patients with Lung CancerJournal of Nuclear Medicine, 2008
- Maximum Standard Uptake Value of Mediastinal Lymph Nodes on Integrated FDG-PET-CT Predicts Pathology in Patients with Non-Small Cell Lung CancerThe Annals of Thoracic Surgery, 2006